54868-4138 Anzemet - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

54868-4138

Brand Name:

Anzemet

Generic Name:

Dolasetron mesylate

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Packages:

Code: 54868-4138-00

Description:

Effective Date: Sept. 11, 1997

Discontinued: June 30, 2010

Code: 54868-4138-01

Description:

Effective Date: Sept. 11, 1997

Discontinued: June 30, 2010

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used